Encompass Health Reports Strong Q4 & FY25 Results, Issues Positive 2026 Guidance
EHC is trading near its 52-week low of $92.53 (11% above the low) on elevated volume (2.7× avg).
Summary
Encompass Health Corp announced strong Q4 and full-year 2025 financial results, with significant growth in revenue and earnings, and provided positive guidance for 2026.
Key Events · Earnings and Guidance · EHC
-
Strong Q4 2025 Financial Performance
Net operating revenue increased by 9.9% to $1,544.6 million, Adjusted EBITDA grew 15.9% to $335.6 million, and Adjusted EPS rose 24.8% to $1.46 compared to Q4 2024.
-
Solid Full Year 2025 Results
For the full year, net operating revenue increased 10.5% to $5,935.2 million, Adjusted EBITDA grew 14.9% to $1,267.9 million, and Adjusted EPS increased 23.0% to $5.45.
-
Positive 2026 Guidance Issued
The company projects 2026 net operating revenue between $6,365 million and $6,465 million, Adjusted EBITDA between $1,340 million and $1,380 million, and Adjusted EPS between $5.81 and $6.10.
-
Significant Capacity Expansion
In 2025, Encompass Health opened 8 new hospitals, adding 390 beds, and expanded existing hospitals by 127 beds, demonstrating continued growth in its inpatient rehabilitation capacity.
Analysis · EHC · Industrial Applications And Services
Encompass Health Corp delivered robust financial results for both the fourth quarter and full year 2025, exceeding prior-year performance across key metrics. The company reported double-digit growth in net operating revenue, Adjusted EBITDA, and Adjusted EPS, driven by strong same-store discharge growth and significant capacity expansion. The positive momentum is expected to continue into 2026, as indicated by the favorable guidance provided. This strong operational execution and optimistic outlook reinforce the company's growth trajectory and solidifies its market position, making this a very important update for investors.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EHC was trading at $102.90 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $10B. The 52-week trading range was $92.53 to $127.99. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.